Collectively, these data suggest that type III IFN, specifically IFNλ1, plays an important role in the induction of IFNβ and other cytokines/chemokines downstream of STING signaling and the subsequent anti-tumor activity. The gene discussed is IFNB1; the disease is neoplasm.